SAN DIEGO, CA / ACCESS Newswire / December 8, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the launch of IBD Precis ™, a next-generation ...
SAN DIEGO, CA / ACCESSWIRE / May 20, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare announced that nine posters on precision-guided care in inflammatory bowel ...
SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, presented seven abstracts on precision-guided care in inflammatory ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
PredictrPK® IFX influenced changes in care in 58% of cases and confirmed current treatment approach in the remaining 42% SAN DIEGO, CA / ACCESSWIRE / December 21, 2023 / Prometheus Laboratories Inc. ( ...